Abstract

The Cardiac Rhythm Device Summit will provide an update on the indications, follow up, and management of cardiac rhythm technology, emphasizing clinical pearls. Hundreds of thousands of patients receive cardiac rhythm devices each year for brady or tachyarrhythmis and heart failure. In addition, the number of people who may benefit from an implantable cardioverter defibrillator (ICD) and/or cardiac resynchronization device (CRT) has substantially increased in the past decade. Evolving device technology has increased programming complexity, follow-up, and management. Cardiac implantable device management related to electrophysiology remains a major part of daily practice for cardiologists, electrophysiologists, and non-physician caregivers involved in the management of these devices.